{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:35:57Z","timestamp":1790116557677,"version":"4.0.1"},"reference-count":212,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The block-and-lock strategy aims to achieve a functional cure for human immunodeficiency virus type 1 (HIV-1) infection by enforcing durable, drug-independent silencing of proviral transcription. Several latency-promoting agents have been described that effectively limit viral reactivation in vitro or in animal models. However, most approaches induce only partial or reversible transcriptional repression and have not yet been translated into safe and effective clinical interventions. This review summarizes the molecular mechanisms underlying block-and-lock strategies and critically evaluates the limitations of current candidate compounds. We highlight recent advances in understanding HIV-1 integration site selection, focusing on the roles of lens epithelium-derived growth factor p75 (LEDGF\/p75) and cleavage and polyadenylation specificity factor subunit 6 (CPSF6) in directing proviral integration toward gene-dense, transcriptionally active chromatin. Pharmacological disruption of the LEDGF\/p75\u2013integrase interaction by LEDGF\/p75 inhibitors (LEDGINs) redirects proviral integration toward less transcriptionally active genomic regions that are more resistant to reactivation. Recent tandem knockout experiments, however, demonstrate that CPSF6 plays a dominant role in guiding HIV-1 integration toward gene-dense, transcriptionally active chromatin. LEDGIN treatment has been linked to the preferential targeting of proviruses to heterochromatin-rich regions within the nuclear interior. By contrast, CPSF6 knockout redirects integration toward peripheral heterochromatin, especially lamina-associated domains (LADs), genomic regions typically exhibiting stronger and more stable transcriptional repression than interior heterochromatin. These findings suggest that therapeutic modulation of CPSF6 may exert a more profound and durable effect on proviral silencing within a block-and-lock framework. Nevertheless, complete CPSF6 ablation is associated with severe cellular toxicity. The challenges associated with CPSF6-related adverse effects and potential strategies to overcome these limitations are discussed.<\/jats:p>","DOI":"10.3390\/ijms27083496","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:29:08Z","timestamp":1776162548000},"page":"3496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Block-and-Lock Approaches for HIV Cure: Mechanistic Insights, Challenges, and Emerging Role of CPSF6"],"prefix":"10.3390","volume":"27","author":[{"given":"Manlio","family":"Tolomeo","sequence":"first","affiliation":[{"name":"Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy"},{"name":"Department of Infectious Diseases, Azienda Ospedaliera Universitaria Policlinico (A.O.U.P.) Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-1796","authenticated-orcid":false,"given":"Antonio","family":"Cascio","sequence":"additional","affiliation":[{"name":"Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy"},{"name":"Department of Infectious Diseases, Azienda Ospedaliera Universitaria Policlinico (A.O.U.P.) Palermo, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., and Cascio, A. (2024). The complex dysregulations of CD4 T cell subtypes in HIV infection. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147512"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., and Cascio, A. (2025). The STAT signaling pathway in HIV-1 infection: Roles and dysregulation. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202508.2068.v1"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., Cavalli, A., and Cascio, A. (2022). Stat1 and its crucial role in the control of viral infections. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23084095"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tolomeo, M., Tolomeo, F., and Cascio, A. (2025). The complex interactions between HIV-1 and human host cell genome: From molecular mechanisms to clinical practice. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202503.1620.v1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41467-025-56116-1","article-title":"Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: An individual data-based meta-analysis of 24 prospective studies","volume":"16","author":"Gunst","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101478","DOI":"10.1016\/j.smim.2021.101478","article-title":"Shocking HIV-1 with immunomodulatory latency reversing agents","volume":"51","author":"Rodari","year":"2021","journal-title":"Semin. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-019-03156-8","article-title":"Strategies to eradicate HIV from infected patients: Elimination of latent provirus reservoirs","volume":"76","author":"Sadowski","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.03.008","article-title":"HIV \u2018shock and kill\u2019 therapy: In need of revision","volume":"166","author":"Abner","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(19)32990-3","article-title":"Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (The RIVER Trial): A phase 2, randomised trial","volume":"395","author":"Fidler","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11538-025-01498-y","article-title":"Modeling the effects of a shock-and-kill treatment for HIV: Latency-reversing agents and natural killer cells","volume":"87","author":"Liu","year":"2025","journal-title":"Bull. Math. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ahlenstiel, C.L., Symonds, G., Kent, S.J., and Kelleher, A.D. (2020). Block and lock HIV cure strategies to control the latent reservoir. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00424"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Vansant, G., Bruggemans, A., Janssens, J., and Debyser, Z. (2020). Block-and-lock strategies to cure HIV infection. Viruses, 12.","DOI":"10.3390\/v12010084"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Moranguinho, I., and Valente, S.T. (2020). Block-and-lock: New horizons for a cure for HIV-1. Viruses, 12.","DOI":"10.3390\/v12121443"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mediouni, S., Lyu, S., Schader, S.M., and Valente, S.T. (2022). Forging a functional cure for HIV: Transcription regulators and inhibitors. Viruses, 14.","DOI":"10.3390\/v14091980"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/infdis\/jiaa681","article-title":"The block-and-lock strategy for human immunodeficiency virus cure: Lessons learned from didehydro-cortistatin A","volume":"223","author":"Li","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2017.09.080","article-title":"In vivo suppression of HIV rebound by didehydro-cortistatin A, a \u201cblock-and-lock\u201d strategy for HIV-1 treatment","volume":"21","author":"Kessing","year":"2017","journal-title":"Cell Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1096\/fj.201801165R","article-title":"The Tat inhibitor didehydro-cortistatin A suppresses SIV replication and reactivation","volume":"33","author":"Mediouni","year":"2019","journal-title":"FASEB J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1038\/s41467-025-59398-7","article-title":"BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription","volume":"16","author":"Pellaers","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1172\/JCI120633","article-title":"Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV","volume":"129","author":"Niu","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e0092323","DOI":"10.1128\/jvi.00923-23","article-title":"CDK8 inhibitors antagonize HIV-1 reactivation and promote provirus latency in T cells","volume":"97","author":"Horvath","year":"2023","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e183084","DOI":"10.1172\/jci.insight.183084","article-title":"Mechanisms and efficacy of small molecule latency-promoting agents to inhibit HIV reactivation ex vivo","volume":"9","author":"Janssens","year":"2024","journal-title":"JCI Insight"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Debyser, Z., Vansant, G., Bruggemans, A., Janssens, J., and Christ, F. (2018). Insight in HIV integration site selection provides a block-and-lock strategy for a functional cure of HIV infection. Viruses, 11.","DOI":"10.3390\/v11010012"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e02328-20","DOI":"10.1128\/AAC.02328-20","article-title":"GS-9822, a preclinical LEDGIN candidate, displays a block-and-lock phenotype in cell culture","volume":"65","author":"Bruggemans","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e0000722","DOI":"10.1128\/mbio.00007-22","article-title":"Single-cell imaging shows that the transcriptional state of the HIV-1 provirus and its reactivation potential depend on the integration site","volume":"13","author":"Janssens","year":"2022","journal-title":"mBio"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1093\/nar\/gkaa536","article-title":"The chromatin landscape at the HIV-1 provirus integration site determines viral expression","volume":"48","author":"Vansant","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"E1054","DOI":"10.1073\/pnas.1524213113","article-title":"A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin","volume":"113","author":"Sowd","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.chom.2018.08.002","article-title":"Capsid-CPSF6 interaction licenses nuclear HIV-1 trafficking to sites of viral DNA integration","volume":"24","author":"Achuthan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1126\/science.abb4808","article-title":"Structural and mechanistic bases for a potent HIV-1 capsid inhibitor","volume":"6514","author":"Bester","year":"2020","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-020-02003-5","article-title":"Lamina-associated domains: Peripheral matters and internal affairs","volume":"21","author":"Briand","year":"2020","journal-title":"Genome Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107009","DOI":"10.1016\/j.ijantimicag.2023.107009","article-title":"Lenacapavir: A novel injectable HIV-1 capsid inhibitor","volume":"63","author":"Hitchcock","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Engelman, A.N. (2021). HIV capsid and integration targeting. Viruses, 13.","DOI":"10.3390\/v13010125"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/S2352-3018(22)00291-0","article-title":"Lenacapavir administered every 26 weeks or daily in combination with oral ART for initial HIV treatment: A randomized, open-label, phase 2 trial","volume":"10","author":"Gupta","year":"2023","journal-title":"Lancet HIV"},{"key":"ref_33","unstructured":"Mounzer, K., Slim, J., Ramgopal, M., Hedgcock, M., Bloch, M., Santana, J., Mendes, I., Guo, Y., Arora, P., and Montezuma-Rusca, J.M. (2024, January 3\u20136). Phase 2 study of switch to daily BIC + LEN in individuals on a complex HIV treatment regimen. Proceedings of the CROI Conference, Denver, CO, USA."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/cid\/ciae522","article-title":"Efficacy and safety of switching to daily Bictegravir plus Lenacapavir from a complex HIV treatment regimen: A randomized, open-label, multicenter phase 2 Study (ARTISTRY-1)","volume":"80","author":"Mounzer","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1080\/14656566.2023.2294918","article-title":"Expanding therapeutic options: Lenacapavir + bictegravir as a potential treatment for HIV","volume":"18","author":"Doan","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/biology1030668","article-title":"Strategies to block HIV transcription: Focus on small molecule Tat inhibitors","volume":"1","author":"Mousseau","year":"2012","journal-title":"Biology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yu, K., Liu, H., and Pan, T. (2025). HIV-1 Tat: Molecular switch in viral persistence and emerging technologies for functional cure. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136311"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jin, H., Li, D., Lin, M.H., Li, L., and Harrich, D. (2020). Tat-based therapies as an adjuvant for an HIV-1 functional cure. Viruses, 12.","DOI":"10.3390\/v12040415"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e02662-18","DOI":"10.1128\/mBio.02662-18","article-title":"Didehydro-cortistatin A inhibits HIV-1 by specifically binding to the unstructured basic region of Tat","volume":"10","author":"Mediouni","year":"2019","journal-title":"mBio"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e00465","DOI":"10.1128\/mBio.00465-15","article-title":"The Tat inhibitor didehydro-cortistatin A prevents HIV-1 reactivation from latency","volume":"6","author":"Mousseau","year":"2015","journal-title":"mBio"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S2352-3018(18)30039-0","article-title":"Barriers and strategies to achieve a cure for HIV","volume":"5","author":"Pitman","year":"2018","journal-title":"Lancet HIV"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ling, L., Leda, A.R., Begum, N., Spagnuolo, R.A., Wahl, A., Garcia, J.V., and Valente, S.T. (2023). Loss of in vivo replication fitness of HIV-1 variants resistant to the Tat inhibitor dCA. Viruses, 15.","DOI":"10.3390\/v15040950"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e01750-18","DOI":"10.1128\/mBio.01750-18","article-title":"Resistance to the Tat inhibitor didehydro-cortistatin A is mediated by heightened basal HIV-1 transcription","volume":"10","author":"Mousseau","year":"2019","journal-title":"mBio"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Shin, Y.H., Kim, D.E., Yu, K.L., Park, C.M., Kim, H.G., Kim, K.C., Bae, S., and Yoon, C.H. (2023). Novel time-resolved fluorescence resonance energy transfer assay for the discovery of small-molecule inhibitors of HIV-1 Tat-regulated transcription. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119139"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Alanazi, A., Ivanov, A., Kumari, N., Lin, X., Wang, S., Kovalskyy, D., and Nekhai, S. (2021). Targeting Tat\u2013TAR RNA interaction for HIV-1 inhibition. Viruses, 13.","DOI":"10.20944\/preprints202106.0565.v1"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ronsard, L., Rai, T., Rai, D., Ramachandran, V.G., and Banerjea, A.C. (2017). In silico analyses of subtype-specific HIV-1 Tat\u2013TAR RNA interaction reveal the structural determinants for viral activity. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.01467"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/nar\/24.20.3974","article-title":"Structure of HIV-1 TAR RNA in the absence of ligands reveals a novel conformation of the trinucleotide bulge","volume":"24","author":"Karn","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1074\/jbc.271.17.10391","article-title":"Visualizing a specific contact in the HIV-1 Tat protein fragment and trans-activation responsive region RNA complex by photocross-linking","volume":"271","author":"Liu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1101\/gad.5.12b.2508","article-title":"Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin","volume":"5","author":"Sheline","year":"1991","journal-title":"Genes Dev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"101390","DOI":"10.1016\/j.jbc.2021.101390","article-title":"Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cells","volume":"297","author":"Chavali","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1002\/chem.201900139","article-title":"\u03b1-Helix-mimetic foldamers for targeting HIV-1 TAR RNA","volume":"25","author":"Maity","year":"2019","journal-title":"Chem. Eur. J."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Khatkar, P., Mensah, G., Ning, S., Cowen, M., Kim, Y., Williams, A., Abulwerdi, F.A., Zhao, Y., Zeng, C., and Le Grice, S.F.J. (2023). HIV-1 transcription inhibition using small RNA-binding molecules. Pharmaceuticals, 17.","DOI":"10.3390\/ph17010033"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.0900629106","article-title":"Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein","volume":"106","author":"Davidson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12977-014-0088-6","article-title":"Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein","volume":"11","author":"Wan","year":"2014","journal-title":"Retrovirology"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Gorrie, D., Bravo, M., and Fan, L. (2024). The Yin and Yang of the natural product triptolide and its interactions with XPB, an essential protein for gene expression and DNA repair. Genes, 15.","DOI":"10.3390\/genes15101287"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"108932","DOI":"10.1016\/j.intimp.2022.108932","article-title":"Therapeutic effect of (5R)-5-hydroxytriptolide (LLDT-8) in SIV infected rhesus monkeys","volume":"110","author":"Lv","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"111173","DOI":"10.1016\/j.intimp.2023.111173","article-title":"Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques","volume":"126","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e01630-22","DOI":"10.1128\/jvi.01630-22","article-title":"A camptothecin analog, topotecan, promotes HIV latency via interference with HIV transcription and RNA splicing","volume":"97","author":"Mukim","year":"2023","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Xu, Y., Peng, X., Zheng, Y., Jin, C., Lu, X., Han, D., Fu, H., Chen, C., and Wu, N. (2021). Inactivation of latent HIV-1 proviral DNA using clustered regularly interspaced short palindromic repeats\/Cas9 treatment and the assessment of off-target effects. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.629153"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","article-title":"In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models","volume":"25","author":"Yin","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12981-022-00483-y","article-title":"CRISPR\/Cas9: A tool to eradicate HIV-1","volume":"19","author":"Bhowmik","year":"2022","journal-title":"AIDS Res. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41434-023-00410-4","article-title":"Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates","volume":"31","author":"Burdo","year":"2024","journal-title":"Gene Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2217887120","DOI":"10.1073\/pnas.2217887120","article-title":"CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice","volume":"120","author":"Dash","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","unstructured":"Presti, R., Kennedy, W., Craddick, T.J., and Gordon, J. (2024, January 7\u201311). First-in-human study of EBT-101 in aviremic HIV-1 infected adults on stable ART. Proceedings of the 27th Annual Meeting of the American Society of Gene & Cell Therapy, Baltimore, MD, USA."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e01423-18","DOI":"10.1128\/mBio.01423-18","article-title":"Splicing factor 3B subunit 1 interacts with HIV Tat and plays a role in viral transcription and reactivation from latency","volume":"9","author":"Kyei","year":"2018","journal-title":"mBio"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.addr.2016.03.005","article-title":"Recent advances in RNAi-based strategies for therapy and prevention of HIV-1\/AIDS","volume":"103","author":"Swamy","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1042\/BST20160060","article-title":"Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas","volume":"44","author":"Berkhout","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13073-015-0174-y","article-title":"RNA interference approaches for treatment of HIV-1 infection","volume":"7","author":"Bobbin","year":"2015","journal-title":"Genome Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"114970","DOI":"10.1016\/j.addr.2023.114970","article-title":"Targeted delivery methods for RNA interference are necessary to obtain a potential functional cure for HIV\/AIDS","volume":"199","author":"Cisneros","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/mtna.2013.64","article-title":"Promoter targeting shRNA suppresses HIV-1 infection in vivo through transcriptional gene silencing","volume":"2","author":"Suzuki","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12977-024-00637-y","article-title":"MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV","volume":"21","author":"Scarborough","year":"2024","journal-title":"Retrovirology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7150\/thno.23085","article-title":"Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e01486-17","DOI":"10.1128\/AAC.01486-17","article-title":"Combinatorial CRISPR-Cas9 and RNA interference attack on HIV-1 DNA and RNA can lead to cross-resistance","volume":"61","author":"Zhao","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bfgp\/elz021","article-title":"CRISPR therapy towards an HIV cure","volume":"19","author":"Gao","year":"2020","journal-title":"Brief Funct. Genomics"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hussein, M., Molina, M.A., Berkhout, B., and Herrera-Carrillo, E. (2023). A CRISPR-Cas cure for HIV\/AIDS. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021563"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Maslennikova, A., and Mazurov, D. (2022). Application of CRISPR\/Cas genomic editing tools for HIV therapy: Toward precise modifications and multilevel protection. Front. Cell Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.880030"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e2100180","DOI":"10.1002\/bies.202100180","article-title":"BRD4 in physiology and pathology: \u201cBET\u201d on its partners","volume":"43","author":"Liang","year":"2021","journal-title":"BioEssays"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nsmb.3228","article-title":"BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin","volume":"23","author":"Devaiah","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"101326","DOI":"10.1016\/j.jbc.2021.101326","article-title":"The intrinsic kinase activity of BRD4 spans its BD2\u2013B\u2013BID domains","volume":"297","author":"Weissman","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1189\/jlb.2RI0616-250R","article-title":"Bromodomain 4: A cellular Swiss Army knife","volume":"100","author":"Devaiah","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1074\/jbc.M111.282855","article-title":"Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes","volume":"287","author":"Cho","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_83","first-page":"232870","article-title":"Brd4 and HEXIM1: Multiple roles in P-TEFb regulation and cancer","volume":"2014","author":"Chen","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/nar\/gkab1228","article-title":"Disrupting the Cdk9\/Cyclin T1 heterodimer of 7SK snRNP for the Brd4 and AFF1\/4 guided reconstitution of active P-TEFb","volume":"50","author":"Zhou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"13690","DOI":"10.1073\/pnas.0705053104","article-title":"Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription","volume":"104","author":"Bisgrove","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Muniz, L., Egloff, S., Ughy, B., J\u00e1dy, B.E., and Kiss, T. (2010). Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001152"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1073\/pnas.1318503111","article-title":"AFF1 is a ubiquitous P-TEFb partner to enable Tat extraction of P-TEFb from 7SK snRNP and formation of SECs for HIV transactivation","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1093\/nar\/gku449","article-title":"Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation","volume":"42","author":"Itzen","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1074\/jbc.RA117.001347","article-title":"Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation","volume":"293","author":"Mbonye","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Krueger, B.J., Varzavand, K., Cooper, J.J., and Price, D.H. (2010). The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012335"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.molcel.2017.07.025","article-title":"The short isoform of BRD4 promotes HIV--1 latency by engaging repressive SWI\/SNF chromatin--remodeling complexes","volume":"67","author":"Conrad","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2174\/1389557516666160611014130","article-title":"An overview on small molecule inhibitors of BRD4","volume":"16","author":"Huang","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_94","first-page":"1021","article-title":"General mechanism of JQ1 in inhibiting various types of cancer","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/nar\/gks976","article-title":"The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat transactivation","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","article-title":"Reactivation of latent HIV-1 by inhibition of BRD4","volume":"2","author":"Zhu","year":"2012","journal-title":"Cell Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"36609","DOI":"10.1074\/jbc.M112.410746","article-title":"Bromodomain and extra-terminal (BET) bromodomain inhibition activates transcription via transient release of positive transcription elongation factor B (P-TEFb) from 7SK small nuclear ribonucleoprotein","volume":"287","author":"Bartholomeeusen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kumar, N., Ma, Z., Long, F., Bonam, S.R., Lai, H.-T., Wu, S.-Y., Chen, H., Hazell, N.C., Bei, J., and Liu, X. (2025). Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580. bioRxiv.","DOI":"10.1371\/journal.ppat.1013449"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e01880-19","DOI":"10.1128\/JVI.01880-19","article-title":"Epigenetic suppression of HIV in myeloid cells by the BRD4-selective small molecule modulator ZL0580","volume":"94","author":"Alamer","year":"2020","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.50.2.547-555.2006","article-title":"Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel I\u03baB kinase inhibitor","volume":"50","author":"Victoriano","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"de Jesus, M.S.M., Macabeo, A.P.G., Ramos, J.D.A., de Leon, V.N.O., Asamitsu, K., and Okamoto, T. (2022). Voacanga globosa Spirobisindole Alkaloids Exert Antiviral Activity in HIV Latently Infected Cell Lines by Targeting the NF-\u03baB Cascade: In Vitro and In Silico Investigations. Molecules, 27, Correction in Molecules 2024, 29, 626. https:\/\/doi.org\/10.3390\/molecules29030626.","DOI":"10.3390\/molecules29030626"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2174\/0929867033457250","article-title":"Nuclear factor kappa B: A potential target for anti-HIV chemotherapy","volume":"10","author":"Pande","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e0006723","DOI":"10.1128\/aac.00067-23","article-title":"Ponatinib represses latent HIV-1 by inhibiting AKT-mTOR","volume":"67","author":"Huang","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s41401-024-01282-z","article-title":"Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR","volume":"45","author":"Cai","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2018.07.026","article-title":"Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4+ T cells in vitro","volume":"523","author":"Nunes","year":"2018","journal-title":"Virology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e01744-18","DOI":"10.1128\/AAC.01744-18","article-title":"Inhibitors of Signaling Pathways That Block Reversal of HIV-1 Latency","volume":"63","author":"Vargas","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0960-9822(00)80086-X","article-title":"Identification of the Nef-associated kinase as p21-activated kinase 2","volume":"9","author":"Renkema","year":"1999","journal-title":"Curr. Biol."},{"key":"ref_108","first-page":"176","article-title":"HIV-1 Nef and host cell protein kinases","volume":"16","author":"Saksela","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Vargas, B., Boslett, J., Yates, N., and Sluis-Cremer, N. (2023). Mechanism by which PF-3758309, a pan isoform inhibitor of p21-activated kinases, blocks reactivation of HIV-1 latency. Biomolecules, 13.","DOI":"10.1101\/2022.08.02.502581"},{"key":"ref_110","first-page":"33","article-title":"Spectrum of CDK9 inhibitor activity against HIV-1 replication among various models of chronic and latent infection","volume":"12","author":"Pisell","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e0107223","DOI":"10.1128\/aac.01072-23","article-title":"Small molecule inhibitors of transcriptional cyclin-dependent kinases impose HIV-1 latency, presenting \u201cblock and lock\u201d treatment strategies","volume":"68","author":"Horvath","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12977-022-00605-4","article-title":"Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency","volume":"19","author":"Dahal","year":"2022","journal-title":"Retrovirology"},{"key":"ref_113","first-page":"371","article-title":"Chromatin-associated regulation of HIV-1 transcription: Implications for the development of therapeutic strategies","volume":"41","author":"Quivy","year":"2007","journal-title":"Subcell. Biochem."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Hokello, J., Sharma, A.L., and Tyagi, M. (2020). Efficient non-epigenetic activation of HIV latency through the T-cell receptor signalosome. Viruses, 12.","DOI":"10.3390\/v12080868"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/epi.11.61","article-title":"Epigenetic regulation of HIV-1 transcription","volume":"3","author":"Tripathy","year":"2011","journal-title":"Epigenomics"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1074\/jbc.M110.103531","article-title":"Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294","volume":"285","author":"Imai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1038\/srep07701","article-title":"Epigenetic heterogeneity in HIV-1 latency establishment","volume":"5","author":"Matsuda","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1073\/pnas.1913754117","article-title":"Exploring histone loading on HIV DNA reveals a dynamic nucleosome positioning between unintegrated and integrated viral genome","volume":"117","author":"Machida","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jmb.2014.07.022","article-title":"Regulation of HIV-1 latency by chromatin structure and nuclear architecture","volume":"427","author":"Lusic","year":"2015","journal-title":"J. Mol. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.18388\/abp.1998_4303","article-title":"Nucleosomes and regulation of gene expression: Structure of the HIV-1 5\u2032 LTR","volume":"45","author":"Garrard","year":"1998","journal-title":"Acta Biochim. Pol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Nguyen, K., Dobrowolski, C., Shukla, M., Cho, W.-K., Luttge, B., and Karn, J. (2021). Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation. PLoS Pathog., 17.","DOI":"10.1101\/2021.08.02.454353"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.chembiol.2007.04.011","article-title":"Specific inhibition of p300-HAT alters global gene expression and represses HIV replication","volume":"14","author":"Mantelingu","year":"2007","journal-title":"Chem. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1128\/JVI.00175-11","article-title":"Inhibition of HIV-1 Tat-mediated transcription by a coumarin derivative, BPRHIV001, through the Akt pathway","volume":"85","author":"Lin","year":"2011","journal-title":"J. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12977-017-0363-4","article-title":"Modulation of chromatin structure by the FACT histone chaperone complex regulates HIV-1 integration","volume":"14","author":"Matysiak","year":"2017","journal-title":"Retrovirology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/JVI.01920-10","article-title":"Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency","volume":"85","author":"Gallastegui","year":"2011","journal-title":"J. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Vanti, M., Gallastegui, E., Respaldiza, I., Rodr\u00edguez-Gil, A., G\u00f3mez-Herreros, F., Jimeno-Gonz\u00e1lez, S., Jordan, A., and Ch\u00e1vez, S. (2009). Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription. PLoS Genet., 5, Correction in PLoS Genet. 2009, 5, 10\u20131371. https:\/\/doi.org\/10.1371\/annotation\/45587774-5d7c-4023-97b0-96833be7ad9a.","DOI":"10.1371\/annotation\/45587774-5d7c-4023-97b0-96833be7ad9a"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Jean, M.J., Hayashi, T., Huang, H., Brennan, J., Simpson, S., Purmal, A., Gurova, K., Keefer, M.C., Kobie, J.J., and Santoso, N.G. (2017). Curaxin CBL0100 blocks HIV-1 replication and reactivation through inhibition of viral transcriptional elongation. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.02007"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e00470-21","DOI":"10.1128\/AAC.00470-21","article-title":"A new small molecule compound, Q308, silences latent HIV-1 provirus by suppressing Tat- and FACT-mediated transcription","volume":"65","author":"Zhou","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"eaav2131","DOI":"10.1126\/sciadv.aav2131","article-title":"Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins","volume":"4","author":"Chang","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"27297","DOI":"10.1074\/jbc.M115.652339","article-title":"FACT proteins, SUPT16H and SSRP1, are transcriptional suppressors of HIV-1 and HTLV-1 that facilitate viral latency","volume":"290","author":"Huang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-981-16-0267-2_4","article-title":"LEDGINs, inhibitors of the interaction between HIV-1 integrase and LEDGF\/p75, are potent antivirals with a potential to cure HIV infection","volume":"1322","author":"Debyser","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Singh, P.K., Li, W., Bedwell, G.J., Fadel, H.J., Poeschla, E.M., and Engelman, A.N. (2022). Allosteric integrase inhibitor influences on HIV-1 integration and roles of LEDGF\/p75 and HDGFL2 host factors. Viruses, 14.","DOI":"10.3390\/v14091883"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/bbrc.1999.1979","article-title":"Lens epithelium-derived growth factor: Effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts","volume":"267","author":"Singh","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1093\/nar\/gkq410","article-title":"High-resolution profiling of the LEDGF\/p75 chromatin interaction in the ENCODE region","volume":"38","author":"Bartholomeeusen","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"11241","DOI":"10.1093\/nar\/gkab886","article-title":"Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF\/p75","volume":"49","author":"Lapaillerie","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1093\/nar\/gkt074","article-title":"Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes","volume":"41","author":"Eidahl","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Maehigashi, T., Ahn, S., Kim, U.I., Lindenberger, J., Oo, A., Koneru, P.C., Mahboubi, B., Engelman, A.N., Kvaratskhelia, M., and Kim, K. (2021). A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF\/p75 integrase interaction site. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009671"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/AAC.00717-12","article-title":"Small-molecule inhibitors of the LEDGF\/p75 binding site of integrase block HIV replication and modulate integrase multimerization","volume":"56","author":"Christ","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Xue, W., Liu, H., and Yao, X. (2014). Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF\/p75 binding site inhibitors. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090799"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e00462-23","DOI":"10.1128\/aac.00462-23","article-title":"Biological and structural analyses of new potent allosteric inhibitors of HIV-1 integrase","volume":"67","author":"Bonnard","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ebiom.2016.04.039","article-title":"LEDGIN-mediated inhibition of integrase\u2013LEDGF\/p75 interaction reduces reactivation of residual latent HIV","volume":"8","author":"Vranckx","year":"2016","journal-title":"eBioMedicine"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1128\/AAC.02719-13","article-title":"Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor","volume":"58","author":"Fenwick","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e0046524","DOI":"10.1128\/mbio.00465-24","article-title":"The structural and mechanistic bases for the viral resistance to allosteric HIV-1 integrase inhibitor pirmitegravir","volume":"15","author":"Dinh","year":"2024","journal-title":"mBio"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e03560-22","DOI":"10.1128\/mbio.03560-22","article-title":"The drug-induced interface that drives HIV-1 integrase hypermultimerization and loss of function","volume":"14","author":"Singer","year":"2023","journal-title":"mBio"},{"key":"ref_146","unstructured":"Ramgopal, M., Benson, P., Williamson, J.C., Berhe, M., Ruane, P., Casanas, B., DeJesus, E., Lucasti, C., Meng, X., and Kim, U.-I. Results from a proof-of-concept clinical trial of pirmitegravir, an investigational HIV-1 allosteric integrase inhibitor (ALLINI). Proceedings of the IDWeek 2025, San Diego, CA, USA, 19\u201322 October 2025."},{"key":"ref_147","unstructured":"HIVIH (2020). A Single Ascending Dose Trial Investigating the Safety, Tolerability and Pharmacokinetics of Orally Administered BDM-2 in Healthy Male Subjects, NCT03634085."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.2174\/1568026619666190208164801","article-title":"Quinoline-based protein-protein interaction inhibitors of LEDGF\/p75 and HIV integrase: An in silico study","volume":"18","author":"Chhokar","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/acs.jcim.7b00402","article-title":"Discovery of a novel HIV-1 integrase\/p75 interacting inhibitor by docking screening, biochemical assay, and in vitro studies","volume":"57","author":"Wang","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ejmech.2016.10.045","article-title":"Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF\/p75 interaction","volume":"125","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1080\/14756366.2020.1743282","article-title":"The selenium-containing drug ebselen potently disrupts LEDGF\/p75 HIV-1 integrase interaction by targeting LEDGF\/p75","volume":"35","author":"Zhang","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/toxsci\/kfab073","article-title":"Species-specific urothelial toxicity with an anti-HIV noncatalytic site integrase inhibitor (NCINI) is related to unusual pH-dependent physicochemical changes","volume":"183","author":"Roberts","year":"2021","journal-title":"Toxicol. Sci."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Kobayashi-Ishihara, M., Terahara, K., Martinez, J.P., Yamagishi, M., Iwabuchi, R., Brander, C., Ato, M., Watanabe, T., Meyerhans, A., and Tsunetsugu-Yokota, Y. (2018). HIV LTR-driven antisense RNA by itself has regulatory function and may curtail virus reactivation from latency. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.01066"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"eadu8014","DOI":"10.1126\/sciadv.adu8014","article-title":"Suppression of HIV-1 transcription and latency reversal via ectopic expression of the viral antisense transcript AST","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Svensson, J.P. (2021). Targeting epigenetics to cure HIV-1: Lessons from (and for) cancer treatment. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.668637"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.1500956","article-title":"Exclusive transduction of human CD4+ T cells upon systemic delivery of CD4-targeted lentiviral vectors","volume":"195","author":"Zhou","year":"2015","journal-title":"J. Immunol."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Cordes, N., Winter, N., Kolbe, C., Kotter, B., Mittelstaet, J., Assenmacher, M., Cathomen, T., Kaiser, A., and Schaser, T. (2022). Adapter-mediated transduction with lentiviral vectors: A novel tool for cell-type-specific gene transfer. Viruses, 14.","DOI":"10.3390\/v14102157"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.016303-0","article-title":"Functions of Tat: The versatile protein of human immunodeficiency virus type 1","volume":"91","author":"Romani","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"12973","DOI":"10.1073\/pnas.1806438115","article-title":"Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex","volume":"115","author":"Hurley","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"9326","DOI":"10.1074\/jbc.REV119.006860","article-title":"Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery","volume":"294","author":"Chavali","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbrc.2023.08.019","article-title":"Structural basis of the human negative elongation factor NELF-B\/C\/E ternary complex","volume":"677","author":"Cao","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.molcel.2024.01.023","article-title":"Distinct negative elongation factor conformations regulate RNA polymerase II promoter-proximal pausing","volume":"84","author":"Su","year":"2024","journal-title":"Mol. Cell"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2022.12.006","article-title":"P-TEFb: The master regulator of transcription elongation","volume":"83","author":"Fujinaga","year":"2023","journal-title":"Mol. Cell"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1038\/s41467-018-06591-6","article-title":"HIV-1 Tat interactions with cellular 7SK and viral TAR RNAs identify dual structural mimicry","volume":"9","author":"Pham","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/nar\/gkm063","article-title":"Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription","volume":"35","author":"Barboric","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"24968","DOI":"10.1074\/jbc.M501431200","article-title":"Identification of a cyclin T-binding domain in HEXIM1 and biochemical analysis of its binding competition with HIV-1 Tat","volume":"280","author":"Schulte","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/nar\/gkz117","article-title":"Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter","volume":"47","author":"Qu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e00053-23","DOI":"10.1128\/jvi.00053-23","article-title":"Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 promotes HIV-1 replication through modulating microRNAs in macrophages","volume":"97","author":"Yuan","year":"2023","journal-title":"J. Virol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"149095","DOI":"10.1016\/j.gene.2024.149095","article-title":"MALAT1 is important for facilitating HIV-1 latency reversal in latently infected monocytes","volume":"936","author":"Rai","year":"2025","journal-title":"Gene"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.virol.2018.07.020","article-title":"HIV-1 replication in CD4+ T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation","volume":"522","author":"Liu","year":"2018","journal-title":"Virology"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2017.03.002","article-title":"The human immunodeficiency virus 1 ASP RNA promotes viral latency by recruiting the polycomb repressor complex 2 and promoting nucleosome assembly","volume":"506","author":"Zapata","year":"2017","journal-title":"Virology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e02254-20","DOI":"10.1128\/mBio.02254-20","article-title":"CPSF6-dependent targeting of speckle-associated domains distinguishes primate from nonprimate lentiviral integration","volume":"11","author":"Li","year":"2020","journal-title":"mBio"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e00490-25","DOI":"10.1128\/jvi.00490-25","article-title":"CPSF6 promotes HIV-1 preintegration complex function","volume":"99","author":"Chaudhuri","year":"2025","journal-title":"J. Virol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1093\/nar\/gkz206","article-title":"Differential role for phosphorylation in alternative polyadenylation function versus nuclear import of SR-like protein CPSF6","volume":"47","author":"Jang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1261\/rna.080108.124","article-title":"Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3\u2032 ends","volume":"30","author":"Liu","year":"2024","journal-title":"RNA"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Cornish, D., Jackson-Jones, K.A., Ling-Hu, T., Simons, L., Cisneros, W., Kuffour, E., Agnes, F., Lee, Y., Bieniasz, P., and Lorenzo-Redondo, R. (2025). Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1013745"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.tim.2024.01.001","article-title":"HIV-1-induced translocation of CPSF6 to biomolecular condensates","volume":"32","author":"Bialas","year":"2024","journal-title":"Trends Microbiol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"10974","DOI":"10.1038\/s41598-023-37364-x","article-title":"Formation of nuclear CPSF6\/CPSF5 biomolecular condensates upon HIV-1 entry into the nucleus is important for productive infection","volume":"13","author":"Luchsinger","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Ge, Y., Huang, J., Chen, R., Fu, Y., Ling, T., Ou, X., Rong, X., Cheng, Y., Lin, Y., and Zhou, F. (2024). Downregulation of CPSF6 leads to global mRNA 3\u2032 UTR shortening and enhanced antiviral immune responses. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012061"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Rohlfes, N., Radhakrishnan, R., Singh, P.K., Li, W., Sowd, G.A., and Engelman, A.N. (2025). The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1012354"},{"key":"ref_181","first-page":"1959","article-title":"Distinct classes of lamina-associated domains are defined by differential patterns of repressive histone methylation","volume":"35","author":"Martin","year":"2025","journal-title":"Genome Res."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Lochs, S.J.A., Kefalopoulou, S., and Kind, J. (2019). Lamina associated domains and gene regulation in development and cancer. Cells, 8.","DOI":"10.3390\/cells8030271"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2017.04.022","article-title":"Lamina-associated domains: Links with chromosome architecture, heterochromatin, and gene repression","volume":"169","author":"Belmont","year":"2017","journal-title":"Cell"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2016.12.005","article-title":"Genome-nuclear lamina interactions: From cell populations to single cells","volume":"43","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_185","first-page":"e50193","article-title":"Cell cycle dynamics of lamina-associated DNA","volume":"21","author":"Vos","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10577-022-09686-5","article-title":"CTCF supports preferentially short lamina-associated domains","volume":"30","author":"Kaczmarczyk","year":"2022","journal-title":"Chromosome Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1038\/s41467-019-12007-w","article-title":"Retroviral integration into nucleosomes through DNA looping and sliding along the histone octamer","volume":"10","author":"Wilson","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"12043","DOI":"10.1128\/JVI.00867-11","article-title":"Gypsy and the birth of the SCAN domain","volume":"85","author":"Emerson","year":"2011","journal-title":"J. Virol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"e01098-21","DOI":"10.1128\/mBio.01098-21","article-title":"Cleavage and polyadenylation specificity factor 6 is required for efficient HIV-1 latency reversal","volume":"12","author":"Zheng","year":"2021","journal-title":"mBio"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e00048-22","DOI":"10.1128\/mmbr.00048-22","article-title":"Capsid-host interactions for HIV-1 ingress","volume":"87","author":"Jang","year":"2023","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"e2420497122","DOI":"10.1073\/pnas.2420497122","article-title":"Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice","volume":"122","author":"Li","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_192","first-page":"449","article-title":"Lenacapavir-induced capsid damage uncovers HIV-1 genomes emanating from nuclear speckles","volume":"45","author":"Klaus","year":"2026","journal-title":"EMBO J."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e171097","DOI":"10.1172\/JCI171097","article-title":"Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones","volume":"133","author":"Dragoni","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1172\/JCI138099","article-title":"HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus","volume":"130","author":"Halvas","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature14226","article-title":"Nuclear architecture dictates HIV-1 integration site selection","volume":"521","author":"Marini","year":"2015","journal-title":"Nature"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"e34655","DOI":"10.7554\/eLife.34655","article-title":"Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells","volume":"7","author":"Battivelli","year":"2018","journal-title":"eLife"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1242\/dev.132605","article-title":"KRAB zinc finger proteins","volume":"144","author":"Ecco","year":"2017","journal-title":"Development"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1038\/s44318-024-00214-1","article-title":"Chromatin protein complexes involved in gene repression in lamina-associated domains","volume":"43","author":"Manzo","year":"2024","journal-title":"EMBO J."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Caruso, L.B., Guo, R., Keith, K., Tempera, I., and Gewurz, B.E. (2022). The nuclear lamina binds the Epstein-Barr virus genome during latency and regulates viral gene expression. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010400"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41467-019-14152-8","article-title":"Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/JVI.06334-11","article-title":"Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome","volume":"86","author":"Ramasubramanyan","year":"2012","journal-title":"J. Virol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00281-020-00792-2","article-title":"Epigenetic lifestyle of Epstein-Barr virus","volume":"42","author":"Buschle","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Murata, T., Sugimoto, A., Inagaki, T., Yanagi, Y., Watanabe, T., Sato, Y., and Kimura, H. (2021). Molecular basis of Epstein-Barr virus latency establishment and lytic reactivation. Viruses, 13.","DOI":"10.3390\/v13122344"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tim.2019.09.002","article-title":"Control of viral latency by episome maintenance proteins","volume":"28","author":"Calderon","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1172\/JCI136225","article-title":"Herpesvirus Latency","volume":"130","author":"Cohen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chom.2016.04.008","article-title":"Epigenetics and genetics of viral latency","volume":"19","author":"Lieberman","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_208","first-page":"e02865-25","article-title":"HIV-1 infection regulates gene expression by altering alternative polyadenylation correlated with CPSF6 and CPSF5 redistribution","volume":"16","author":"Luchsinger","year":"2025","journal-title":"mBio"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"RP103725","DOI":"10.7554\/eLife.103725.3","article-title":"Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear speckles","volume":"13","author":"Tomasini","year":"2026","journal-title":"eLife"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1038\/s41467-022-33662-6","article-title":"Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection","volume":"13","author":"Wei","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17460441.2023.2157401","article-title":"The discovery and design of novel HIV-1 capsid modulators and future perspectives","volume":"18","author":"Ding","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molmed.2025.01.013","article-title":"Considerations for capsid-targeting antiretrovirals in pre-exposure prophylaxis","volume":"31","author":"McFadden","year":"2025","journal-title":"Trends Mol. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:32:03Z","timestamp":1776162723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":212,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27083496"],"URL":"https:\/\/doi.org\/10.3390\/ijms27083496","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}